From hydroxychloroquine to ivermectin: how unproven "cures" can go viral.

Taccone, Fabio Silvio; Hites, Maya; Dauby, Nicolas

Taccone, Fabio Silvio; Hites, Maya; Dauby, Nicolas.

Taccone FS; Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: fabio.taccone@ulb.be.
Hites M; Department of Infectious Disease, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Dauby N; Department of Infectious Diseases, St. Pierre Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Clin Microbiol Infect ; 28(4): 472-474, 2022 04.

Article in English | MEDLINE | ID: covidwho-1936211

Subject(s)

COVID-19; Hydroxychloroquine; Humans; Hydroxychloroquine/therapeutic use; Ivermectin/therapeutic use; SARS-CoV-2

Keywords

COVID-19; Effectiveness; Hydroxychloroquine; Infodemic; Ivermectin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hydroxychloroquine Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google